The plasma levels of sCD25, TIM-3, galectin-9, PD-1, and PD-L1 were significantly increased in patients with CLL compared to the control group, p < 0.0001. This evidence concerns the gene HAVCR2 and B-cell chronic lymphocytic leukemia.